Search

everythinglearnresearchcommunity

for

Search:↓

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

Finasteride increases hair count and improves hair growth with low risk of side effects.

Minoxidil and finasteride treat hair loss in men, while minoxidil treats hair loss in women.

Effective hair loss assessment requires a mix of precise measurement methods.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Propranolol is effective and safe for treating infantile hemangioma, but more research is needed for dosing and monitoring guidelines.

Taking oral testosterone with or without dutasteride increases testosterone levels and could be an effective treatment for low testosterone.

AGA is a genetic, hormonal hair loss treated with finasteride, minoxidil, and supplements, but new compounds are being developed.

Use antiandrogens and other treatments for hair loss.

Women of color in Northern Manhattan view hair care as important to their identity and culture, and education on harmful chemicals in hair products is needed.

Atopic dermatitis may have genetic causes and can be treated with pharmacologic methods, glycerin creams, and controlling Staphylococcus aureus colonization.

Laser and light treatments can effectively remove hair long-term.

Finasteride is effective for male hair loss, teledermatology is accurate and accepted, and cyclosporin helps treat toxic epidermal necrolysis.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Low vitamin D levels may affect ovulation and progesterone in infertile women.

Smart hydrogel dressings could improve diabetic wound healing by adjusting to wound conditions and controlling drug release.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

Pegvaliase effectively reduces blood phenylalanine levels in most PKU patients, but requires personalized plans and good communication to manage side effects.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

There is no standardized treatment for hidradenitis suppurativa, and individualized plans are needed.

Plasma-activated liquid can kill harmful cells, speed up wound healing, and potentially treat cancer without damaging healthy cells.

Light therapy might help treat hereditary hair loss by improving hair follicle growth in lab cultures.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

SER120 nasal spray effectively reduces nighttime urination and is safe for patients.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

In September 2016, there were major advancements and promising clinical trials in stem cell research and regenerative medicine.

Androgenetic alopecia trials in the U.S. lack racial and ethnic diversity, limiting their applicability.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.